Diabetes Clinical Trial
Official title:
Evaluation of Group Lifestyle Balance Maintenance Strategies
| Verified date | January 2016 |
| Source | University of Pittsburgh |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Interventional |
Heart disease is a leading cause of death in people in the United States. It is a major
problem for those with diabetes. Conditions called the metabolic syndrome and pre-diabetes
increase risk for diabetes and heart disease. The metabolic syndrome is a group of disorders
that occur at the same time. Overall, one in four American adults has the metabolic
syndrome. It is more common in people over the age of 40. The metabolic syndrome includes:
1) large waist size, 2) high triglycerides, 3) low HDL cholesterol, 4) high blood pressure
and 5) high fasting blood sugar. People with the metabolic syndrome have at least three of
these five risk factors. Pre-diabetes is considered to be present in those with high fasting
blood sugar levels below the diabetes range.
Research has shown that type 2 diabetes and the metabolic syndrome may be prevented or
delayed by making lifestyle changes. It is not known what will most help people continue
these healthy changes over time. The purpose of this study is to look at ways to help people
continue the healthy lifestyle changes they have made while taking part in a diabetes
prevention program called Group Lifestyle Balance (GLB).
| Status | Completed |
| Enrollment | 60 |
| Est. completion date | August 2010 |
| Est. primary completion date | August 2010 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: Non-diabetic patients with metabolic syndrome AND/OR pre-diabetes are eligible for this project based on the following criteria: 1. Metabolic Syndrome: Patients with BMI = 25 kg/m2, with at least 3 of the following risk factors for metabolic syndrome: - Waist circumference (>40 inches men, >35 inches women) - Blood pressure =130 mmHg (systolic) or =85 mmHg (diastolic) OR history of diagnosed hypertension - Low HDL level (<40mg/dL men, <50 mg/dL women) - Elevated triglyceride level =150 mg/dL - Fasting glucose =100mg/dL and <126mg/dL 2. Pre-diabetes: Patients with a BMI =25 kg/m2 and pre-diabetes (fasting glucose =100 mg/dL and <126mg/dL) All measures should have been taken within one year of enrollment into the study. A permission for physical activity form must be signed by the participant's physician in order to take part in the study. Exclusion Criteria: - Previous diabetes or diabetes diagnosed as a result of the screening - Age <18 years old - Women who are currently (or within past 6-weeks) pregnant or lactating - Any patient deemed by their physician not to be a candidate - Any patient planning to leave the area before the end of the GILS - Any patient who is unable to provide informed consent |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| United States | Diabetes Prevention Support Center | Pittsburgh | Pennsylvania |
| Lead Sponsor | Collaborator |
|---|---|
| University of Pittsburgh | Robert C. Atkins Foundation |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in Weight | Weight was measured twice without shoes with the average computed; participants were asked to remove their shoes at each measure. | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | No |
| Secondary | Change in Total Cholesterol | Total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides and fasting plasma glucose were measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant. | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | No |
| Secondary | Change in HDL Cholesterol | Total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides and fasting plasma glucose were measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant. | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | No |
| Secondary | Change in LDL Cholesterol | Total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides and fasting plasma glucose were measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant. | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | No |
| Secondary | Change in Triglycerides | Total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides and fasting plasma glucose were measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant. | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | No |
| Secondary | Change in Fasting Glucose | Total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides and fasting plasma glucose were measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant. | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | No |
| Secondary | Change in HbA1c | Collected via venous blood draw. | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | No |
| Secondary | Change in Systolic Blood Pressure | Blood pressure was measured in a sitting position in the right arm after resting for five minutes. First appearance and last heard (phase V) Korotkoff's sounds were used to define the pressure readings; the measures were repeated twice with a thirty second wait between each reading. | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | No |
| Secondary | Change in Diastolic Blood Pressure | Blood pressure was measured in a sitting position in the right arm after resting for five minutes. First appearance and last heard (phase V) Korotkoff's sounds were used to define the pressure readings; the measures were repeated twice with a thirty second wait between each reading. | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | No |
| Secondary | Change in Waist Circumference | Waist circumference was measured at the midpoint between the lower rib margin and the iliac crest; the measurement was repeated twice and the average computed. | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05594446 -
Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
|
||
| Completed |
NCT03975309 -
DHS MIND Metabolomics
|
||
| Completed |
NCT01855399 -
Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes
|
N/A | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
| Recruiting |
NCT05007990 -
Caregiving Networks Across Disease Context and the Life Course
|
||
| Active, not recruiting |
NCT04420936 -
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program
|
N/A | |
| Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
| Completed |
NCT04903496 -
Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
|
||
| Completed |
NCT01437592 -
Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT03390179 -
Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Recruiting |
NCT05294822 -
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
|
N/A | |
| Completed |
NCT04427982 -
Dance and Diabetes/Prediabetes Self-Management
|
N/A | |
| Completed |
NCT02356848 -
STEP UP to Avert Amputation in Diabetes
|
N/A | |
| Completed |
NCT03292185 -
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
|
Phase 1 | |
| Active, not recruiting |
NCT05477368 -
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
|
N/A | |
| Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 |